As we mentioned yesterday, Alex Rodriguez had his long-awaited meeting with MLB’s investigators on Friday. Now we have the fallout.
According to Bill Madden and Teri Thompson of the New York Daily News, lawyers for Rodriguez are internally discussing the possibility of a plea deal with MLB. It’s believed that MLB also broached the possibility of a settlement with Ryan Braun and other players connected to Biogenesis.
According to another source, Rodriguez’s meeting with MLB ended at about 4 p.m., and a clearly shaken Rodriguez then met with MLB Players Association reps for an hour and a half to discuss what had been outlined by MLB officials. When Rodriguez didn’t show up at the Yankee complex, GM Brian Cashman then tried to reach the three-time AL MVP, who told him that he “just couldn’t make it.”
Meanwhile, an A-Rod spokesman told The News Saturday night in reference to a possible plea deal that “nobody from Alex’s team has made any such comments, and as we have said before, we are respecting the process and following the procedures as outlined in the joint agreement.”
As The News has reported, MLB is believed to have extensive evidence, including Bosch’s own testimony, that Rodriguez committed multiple violations of the joint drug agreement, including acquiring performance-enhancing drugs from Bosch for several years. The self-described “biochemist” has been cooperating with MLB for several weeks in exchange for being dropped from baseball’s lawsuit against him for tortious interference with its player contracts, indemnifying him for legal expenses and putting in a good word for him with law enforcement, and he is believed to have provided proof of his dealings with Rodriguez.
“I can see a scenario where if they’ve got multiple offenses (against A-Rod) that rather than going for his career with an arbitrator, baseball might settle on something like 150 games,” said one of the sources.
According to the Joint Drug Agreement, players are suspended 50 games for a first violation, 100 games for a second, and receive a lifetime ban for a third. As a result, it’s unclear where the 150-game number is coming from, but MLB could be floating it as a compromise if they have a legitimate case for a lifetime ban. Rodriguez would be entitled to an appeal, but a plea deal could be more appealing than hoping that an arbitrator will rule in his favor, especially if his legal team believes the evidence against him is significant and credible. In addition to his career potentially being on the line, Rodriguez still has $100 million remaining on his contract with the Yankees.
MLB.com’s Jenifer Langosch reports that Cardinals’ shortstop Aledmys Diaz has been sporting a new look around Busch Stadium with a pair of “strobe glasses,” technology-enhanced specs designed to help athletes focus on the ball. Like a strobe light, the lenses of these glasses affect a player’s vision by rapidly changing opacity, giving its wearers the illusion that the objects they see are moving more slowly than normal. Once a player adjusts to the new speed of play, they gain a greater sense of control and are able to time their actions with more precision.
Diaz isn’t the first MLB player to utilize the technology, just the first Cardinals’ player to do so. It’s been tested by Bryce Harper, Corey Brown, Tommy Joseph, Austin Hedges and Joe Mauer, among others around the league, and has been used for everything from refining a catcher’s reflexes behind the plate to tweaking a hitter’s ability to track a pitch. Per Langosch, Diaz has been using the glasses to hone in on the ball during pregame drills, increasing both his confidence and response time on the field and improving his defense at short.
The shortstop has been the focus of some concern this season after seeing a sizable dip in his production at the plate, and his five fielding errors, 0.6 UZR and 0.6 fWAR haven’t helped matters, either. He sustained a minor thumb injury during an at-bat on Friday night, and was left off of the Cardinals’ starting lineup on Saturday, though manager Mike Matheny didn’t rule out his ability to pinch-hit during the series. While the strobe glasses are a good start, Diaz will need more than a pair of specs to match the spotlight-worthy performance he turned out during his rookie season in 2016.
Red Sox’ left-hander Eduardo Rodriguez may finally get a chance at cracking the rotation again, assuming all goes well in Double-A Portland first. Rodriguez took the field prior to the club’s afternoon session with the Angels, firing 68 pitches in a simulated game as he prepared for an upcoming rehab assignment in Portland on Thursday.
The 24-year-old southpaw suffered a right knee subluxation during pregame warmups on June 1, and it’s been a slow path to recovery ever since. It’s not the first time Rodriguez has had issues with his right knee — he sustained a similar injury during spring training last year — and this time around, the Red Sox weren’t about to gamble with their starter’s health. Ian Browne of MLB.com reports that Rodriguez was put in a knee brace and underwent exercises designed to help him regain some mobility and stability while he worked back up to full strength on the mound.
He’ll still need to prove he can throw a 75- to 80-pitch outing in Double-A, and barring any significant setbacks, will likely rejoin the Red Sox’ pitching staff when they visit the Rangers next month. In the meantime, the club will continue to cycle starters through the No. 5 spot, which has seen no fewer than three different pitchers since Rodriguez hit the disabled list. The lefty is 4-2 in 10 starts this season after logging a 3.54 ERA, 3.1 BB/9 and career-high 9.6 SO/9 through his first 61 innings.